Surface engineered and ligand anchored nanobioconjugate: An effective therapeutic approach for oral insulin delivery in experimental diabetic rats

Colloids and Surfaces B: Biointerfaces

Volumn 127, Issue , 2015, Pages 172-181

  Sharma, Rajeev ^a   Gupta, Umesh ^b   Garg, Neeraj K ^a   Tyagi, Rajeev K ^c,d   Jain, N K ^a  

^a DR H S GOUR UNIVERSITY   (India)

^b CENTRAL UNIVERSITY OF RAJASTHAN   (India)

^c AUGUSTA UNIVERSITY   (United States)

^d REGIONAL CENTRE FOR BIOTECHNOLOGY   (India)

Author keywords

Concanavalin A; Insulin oral delivery; Nanoparticles; PEGylation; PLGA

Indexed keywords

BIOCHEMISTRY; COPOLYMERS; ENCAPSULATION; FOURIER TRANSFORM INFRARED SPECTROSCOPY; NANOPARTICLES; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARTICLE SIZE; RATS; SPECTRUM ANALYSIS; SYNTHESIS (CHEMICAL);

CONCANAVALIN A; ENCAPSULATION EFFICIENCY; ENTRAPMENT EFFICIENCY; ORAL BIOAVAILABILITIES; ORAL DELIVERY; PEGYLATION; PLGA; POLYDISPERSITY INDICES;

INSULIN;

CONCANAVALIN A; GLUCOSE; INSULIN; MACROGOL; POLYGLACTIN; GLUCOSE BLOOD LEVEL; LIGAND; MACROGOL DERIVATIVE; NANOCONJUGATE; NANOPARTICLE; POLYGLYCOLIC ACID;

AGGLUTINATION TEST; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BICINCHONINIC PROTEIN ASSAY; BINDING AFFINITY; CELL TRANSPORT; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; DRUG STABILITY; ENTRAPMENT; EXPERIMENTAL DIABETES MELLITUS; FEMALE; FLUORESCENCE MICROSCOPY; GLUCOSE BLOOD LEVEL; IN VITRO STUDY; IN VIVO STUDY; INFRARED SPECTROSCOPY; INTESTINE ABSORPTION; LIGAND AGGLUTINATION TEST; LIGAND BINDING; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; POLYDISPERSITY INDEX; PROTEIN DETERMINATION; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; SCANNING ELECTRON MICROSCOPY; SYNTHESIS; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL; ANIMAL; BLOOD; CACO 2 CELL LINE; CHEMISTRY; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; ENDOCYTOSIS; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; METABOLISM; ORAL DRUG ADMINISTRATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROCEDURES; SPRAGUE DAWLEY RAT; TRANSPORT AT THE CELLULAR LEVEL; ULTRASTRUCTURE;

RATTUS;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL TRANSPORT; BLOOD GLUCOSE; CACO-2 CELLS; CONCANAVALIN A; DIABETES MELLITUS, EXPERIMENTAL; DRUG DELIVERY SYSTEMS; DRUG LIBERATION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENDOCYTOSIS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; INSULIN; LIGANDS; NANOCONJUGATES; NANOPARTICLES; POLYETHYLENE GLYCOLS; POLYGLYCOLIC ACID; PROTON MAGNETIC RESONANCE SPECTROSCOPY; RATS, SPRAGUE-DAWLEY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 84922471677     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2015.01.035     Document Type: Article

References (45)

1. Hamman J.H., Enslin G.M., Kotze F. BioDrugs 2005, 19:165-177.
2. Ghilzai N.M.K. Drug Dev. Ind. Pharm. 2003, 29:253-265.
3. Agarwal V., Khan M.A. Pharm. Technol. 2001, 10:76-90.
4. Thwaites D.T., Anderson C.M. Exp. Physiol. 2007, 92:603-619.
5. Li Y.X., Xiong Q.H., Li Y.P., Guo L., Li Z.L., Gong Y.C. Biointerfaces 2013, 111:282-288.
6. Mukhopadhyay P., Chakraborty S., Bhattacharya S., Mishra R., Kundu P.P. Int. J. Biol. Macromol. 2014, 72:640-648.
7. Hosseininasab S., Roghiyeh P.A., Khandaghi A.A., Nasrabadi H.T., Koshki K.N., Akbarzadeh A., Joo S.W., Hanifehpour Y., Davaran S. Chem. Biol. Drug Des. 2014, 84(3):307-315.
8. Zhang Y., Du X., Zhang Y., Li G., Cai C., Xu J., Tang X. Macromol. Biosci. 2014, 14(6):842-852.
9. Moghassemi S., Parnian E., Hakamivala A., Darzianiazizi M., Vardanjani M.M., Kashanian S., Larijani B., Omidfar K. Mater. Sci. Eng. C 2015, 46:333-340.
10. Garg N.K., Dwivedi P., Campbell C., Tyagi R.K. Eur J Pharm Sci. 2012, 47(5):1006-1014.
11. Liu J., Shapiro J.I. Biol. Res. Nurs. 2003, 5:117-128.
12. Jin Y., Song Y., Zhu X., Zhou D., Chen C., Zhang Z., Huang Y. Biomaterials 2012, 33(5):1573-1582.
13. Liu X., Liu C., Zhang W., Xie C., Wei G., Lu W. Int. J. Pharm. 2013, 448(1):159-167.
14. Zhang X., Qi J., Lu Y., He W., Li X., Wu W. Nanomedicine 2014, 10(1):167-176.
15. Andreani T., de Kiill C.P., Souza A.L., Joana F.F., Lisete F.J.F., Santosa D.L., Garcia M.L., Gremião M.P., Souto E.B., Silva A.M. Colloids Surf. B: Biointerfaces 2014, 10.1016/j.colsurfb.2014.10.047.
16. Salama N.N., Eddington N.D., Fasano A. Adv. Drug Deliv. Rev. 2006, 58:15-28.
17. Garg N.K., Mangal S., Khambete H., Tyagi R.K. Recent Pat. Drug Deliv. Formul. 2010, 4(2):114-128.
18. Ramachandran R., Paul W., Sharma C.P. J. Biomed. Mater. Res. B: Appl. Biomater. 2009, 88(1):41-48.
19. Andreani T., de Souza A.L., Kiill C.P., Lorenzón E.N., Fangueiro J.F., Calpena A.C., Chaud M.V., Garcia M.L., Gremião M.P., Silva A.M., Souto E.B. Int. J. Pharm. 2014, 473(1-2):627-635.
20. Lehr C.M., Lee V.H. Pharm. Res. 1999, 10:1796-1799.
21. Lehr C.M. J. Control. Release 2000, 65(1-2):19-29.
22. Clark M.A., Hirst B.H., Jepson M.A. Adv. Drug Deliv. Rev. 2000, 43(2-3):207-223.
23. Wood K.M., Stone G., Peppas N.A. J. Control. Release 2006, 28(1162):e66-e80.
24. Werle M., Makhlof A., Takeuchi H. Chem. Pharm. Bull. (Tokyo) 2010, 58(3):432-434.
25. Makhlof A., Fujimoto S., Tozuka Y., Takeuchi H. Eur. J. Pharm. Biopharm. 2011, 77(2):216-224.
26. Varshosaz J., Moazen E. Pharm. Dev. Technol. 2014, 19(5):605-617.
27. Ezpeleta I., Arangoa M.A., Irache J.M., Stainmesse S., Chabenat C., Popineau Y., Orecchioni A.M. Int. J. Pharm. 1999, 191:25-32.
28. Li X., Guo S., Zhu C.Q., Zhu Y., Gan J., Rantanen R.L., Rahbek L., Hovgaard Y.M. Biomaterials 2013, 34:9678-9687.
29. Chen M.C., Sonaje K., Chen K.J., Sung H.W. Biomaterials 2011, 32:9826-9838.
30. Damge C., Reis C.P., Maincent P. Expert Opin. Drug Deliv. 2008, 5:45-68.
31. Damge C., Socha M., Ubrich N., Maincent P. J. Pharm. Sci. 2010, 99:879-889.
32. Hurkat P., Jain A., Jain A., Shilpi S., Gulbake A., Jain S.K. J. Nanoparticle Res. 2012, 14:12-19.
33. Viehof A., Javot L., Beduneau A., Pellequer Y., Lamprecht A. Int. J. Pharm. 2013, 443:169-174.
34. Patil Y.B., Toti U.S., Ma A., Khdair L., Panyam J. Biomaterials 2008, 30:859-866.
35. Yin Y., Chen D., Qiao M., Lu Z., Hu H. J. Control. Release 2006, 16:337-345.
36. Tewes F., Munnier E., Antoon B., Okassa N., Jonathan S.C., Marchais H., Eyrolles L.D., Souse M., Dubois P., Chopra I. Eur. J. Pharm. Biopharm. 2007, 66:488-492.
37. Alonso M.J. Nanoparticulate drug carrier technology. Microparticulate systems for the delivery of proteins and vaccines 1996, 203-242. Marcel Dekker, New York. S. Cohen, H. Bernstein (Eds.).
38. Krauland A.H., Alonso M.J. Int. J. Pharm. 2007, 340:134-142.
39. Reis C.P., Ribeiro A.J., Houng S., Veiga F., Neufeld R.J. Eur. J. Pharm. Sci. 2007, 30:392-397.
40. Chen H., Torchilin V., Langer R. Pharm. Res. 1996, 13:1378-1383.
41. Wilson K., Walker J. Principle and techniques of biochemistry and molecular biology 2004, 349-378. Cambridge University Press, New York.
42. Chalasani K.B., Russell-Jones G.J., Yandrapu S.K., Diwan P.V., Jain S.K. J. Control. Release 2007, 117:421-429.
43. Chalasani K.B., Russell-Jones G.J., Jain A.K., Diwan P.V., Jain S.K. J. Control. Release 2007, 122:141-150.
44. Florence A.T. Pharm. Res. 1997, 14:259-266.
45. Iwanaga K., Ono S., Narioka K., Kakemi M., Morimoto K., Yamashito S., Namba Y., Oku N. J. Pharm. Sci. 1999, 88:248-252.